Total Payments
$13,762
2024 Payments
$3,297
Companies
56
Transactions
865
Medicare Patients
4,100
Medicare Billing
$835,333
Payment Breakdown by Category
Food & Beverage$13,660 (99.3%)
Other$73.66 (0.5%)
Education$27.81 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,660 | 858 | 99.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $73.66 | 4 | 0.5% |
| Education | $27.81 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,406 | 98 | $0 (2024) |
| Amgen Inc. | $1,029 | 68 | $0 (2022) |
| UCB, Inc. | $963.93 | 65 | $0 (2024) |
| SK Life Science, Inc. | $669.15 | 36 | $0 (2024) |
| Celgene Corporation | $635.26 | 69 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $608.14 | 42 | $0 (2024) |
| Lilly USA, LLC | $502.94 | 30 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $497.49 | 23 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $455.35 | 32 | $0 (2024) |
| Genentech USA, Inc. | $393.58 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,297 | 201 | ABBVIE INC. ($576.28) |
| 2023 | $3,377 | 207 | ABBVIE INC. ($472.47) |
| 2022 | $2,648 | 178 | Amgen Inc. ($225.05) |
| 2021 | $1,910 | 126 | Biohaven Pharmaceuticals, Inc. ($256.38) |
| 2020 | $769.08 | 48 | UCB, Inc. ($127.57) |
| 2019 | $1,059 | 63 | UCB, Inc. ($216.22) |
| 2018 | $636.61 | 38 | Amgen Inc. ($280.91) |
| 2017 | $65.87 | 4 | Impax Laboratories, Inc. ($34.80) |
All Payment Transactions
865 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Neurology | ||||||
| 12/18/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/17/2024 | Biogen, Inc. | QALSODY (Drug), SPINRAZA | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Neurology | ||||||
| 12/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/12/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: EPILEPSY | ||||||
| 12/11/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $16.52 | General |
| 12/09/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: PAIN | ||||||
| 11/21/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Neurology | ||||||
| 11/20/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/20/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $4.58 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $15.22 | General |
| 11/13/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: NEUROLOGY | ||||||
| 11/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Neuropsychiatry | ||||||
| 11/08/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/07/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/06/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Neuromodulation | ||||||
| 11/06/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: EPILEPSY | ||||||
| 11/05/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $12.38 | General |
| Category: Neuroscience | ||||||
| 10/31/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $2.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 968 | 19,764 | $773,608 | $210,402 |
| 2022 | 12 | 974 | 19,850 | $679,292 | $212,734 |
| 2021 | 18 | 1,098 | 17,364 | $687,428 | $224,435 |
| 2020 | 19 | 1,060 | 15,067 | $614,096 | $187,761 |
Total Patients
4,100
Total Services
72,045
Medicare Billing
$835,333
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 29 | 18,000 | $227,700 | $87,901 | 38.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 273 | 422 | $120,939 | $35,018 | 29.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 228 | 441 | $142,968 | $31,076 | 21.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 84 | 84 | $60,671 | $12,980 | 21.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 108 | 108 | $48,093 | $12,393 | 25.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 72 | 73 | $32,802 | $6,191 | 18.9% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 45 | 45 | $27,296 | $5,897 | 21.6% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 18 | 47 | $31,698 | $5,776 | 18.2% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Office | 2023 | 15 | 15 | $23,340 | $4,515 | 19.3% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 15 | 15 | $14,658 | $3,094 | 21.1% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 11 | 11 | $9,207 | $2,057 | 22.3% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2023 | 15 | 27 | $22,433 | $1,909 | 8.5% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 22 | 36 | $9,163 | $1,271 | 13.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 33 | 440 | $2,640 | $326.19 | 12.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 37 | 18,330 | $223,695 | $88,242 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 258 | 407 | $108,458 | $33,860 | 31.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 239 | 412 | $111,846 | $31,158 | 27.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 123 | 123 | $51,282 | $14,132 | 27.6% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 88 | 88 | $50,457 | $14,050 | 27.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 77 | 79 | $28,419 | $7,652 | 26.9% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Office | 2022 | 21 | 21 | $32,676 | $6,570 | 20.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 23 | 50 | $30,824 | $6,147 | 19.9% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 40 | 40 | $18,949 | $5,070 | 26.8% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 20 | 20 | $13,460 | $3,886 | 28.9% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 30 | 36 | $7,763 | $1,760 | 22.7% |
About Dr. Daniel Kimple, MD
Dr. Daniel Kimple, MD is a Neurology healthcare provider based in Quincy, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2012. The National Provider Identifier (NPI) number assigned to this provider is 1699030551.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Kimple, MD has received a total of $13,762 in payments from pharmaceutical and medical device companies, with $3,297 received in 2024. These payments were reported across 865 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($13,660).
As a Medicare-enrolled provider, Kimple has provided services to 4,100 Medicare beneficiaries, totaling 72,045 services with total Medicare billing of $835,333. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Quincy, IL
- Active Since 07/06/2012
- Last Updated 04/29/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1699030551
Products in Payments
- Aimovig (Biological) $878.40
- Briviact (Drug) $740.42
- NURTEC ODT (Drug) $694.87
- ZEPOSIA (Drug) $604.78
- UBRELVY (Drug) $547.90
- BOTOX (Biological) $500.89
- WAKIX (Drug) $455.67
- NUPLAZID (Drug) $455.35
- EMGALITY (Drug) $418.76
- AUBAGIO (Drug) $360.51
- APTIOM (Drug) $356.32
- INGREZZA (Drug) $353.21
- OCREVUS (Biological) $350.81
- QULIPTA (Drug) $276.14
- RYTARY (Drug) $269.92
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $269.37
- TYSABRI (Biological) $217.90
- VYVGART (Drug) $198.99
- ONPATTRO (Drug) $189.50
- AUSTEDO (Drug) $188.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Quincy
Dr. Anil Nair, Md, MD
Neurology — Payments: $326,656
Neurology $326,656
Dr. Austin Hake, M.d, M.D
Neurology — Payments: $31,910
Neurology $31,910
Douglas Sullivant, Md, MD
Neurology — Payments: $15,429
Neurology $15,429
Dr. Ahmed Jouan
Neurology — Payments: $9,921
Neurology $9,921
James Won, Md, MD
Neurology — Payments: $691.46
Neurology $691.46
Linda Johnson, M.d, M.D
Neurology — Payments: $16.83
Neurology $16.83